Therefore, to investigate whether human MSCs improved inflammation-related diseases via increasing IL-10 producing Bregs, we employed the murine colitis model, which has been widely used to evaluate the immunomodulatory properties of human MSCs 54-56. The gene discussed is IL10; the disease is colitis.